Independent medical education
Accredited CME for continuing professional development
CDK4/6 inhibitor selection eLearning
Follow three patient case studies in this interactive module
Early breast cancer and risk stratification eLearning
Learn about early breast cancer risk stratification and management
In practice: Anti-TNF biosimilars in rheumatic disease
Following our introductory episodes, these EACCME®-accredited podcasts explore best use of anti-TNF biosimilars in rheumatology clinical practice, with host Peter Taylor.
Symposium at ASCO 2023: Optimizing first-line treatment selection in Ph+ ALL
Symposium at ASCO 2023, Lead from the frontline: Optimizing first-line treatment selection in Ph+ ALL.
COMy 2023: Management of RRMM in older and frail patients
COMy 2023: Management of RRMM in older and frail patients
AATD liver disease podcast series
Take part in our interactive podcast series to explore the role of alpha anti-trypsin deficiency (AATD) in liver disease.
Learning Zones
Advances in HS
The latest updates in HS from the 2024 European Hidradenitis Suppurativa Foundation Conference, 7–9 February in Lyon
Alopecia areata Learning Zone
Unmet needs in alopecia areata, with a focus on the burden of disease, psychosocial impact on patients, developing management plans and potential emerging treatments.
Chronic Kidney Disease Learning Zone
Chronic Kidney Disease (CKD) is a disease that can often lead to a need for haemodialysis and kidney transplantation. New CKD treatments are emerging which focus on delaying CKD disease progression and the need for transplantation.
CDK4/6 inhibitors in breast cancer
Are you familiar with the clinical trial evidence that could help you to select the best cyclin dependent kinase 4/6 (CDK4/6) inhibitor for your metastatic breast cancer patient?
mCRPC in focus
Unmet needs in the management of mCRPC, with a focus on treatments.
Ulcerative colitis Learning Zone
Explore the role of biologics and targeted small molecules in UC management, and listen to expert insights on integrating them into practice.
Introducing vasomotor symptoms
Vasomotor symptoms (VMS) remain one of the most impactful aspects of menopause.
Learn more about their impact and the treatment options available with "VMS breakthroughs" a 4 article series focused on VMS
Future breast cancer care: ESMO Breast Cancer 2024
Read about the latest updates in breast cancer research presented at ESMO Breast Cancer 2024, from the experts who attended.
AL amyloidosis interactive patient journey
Make your own clinical decisions for managing a patient with AL amyloidosis in this interactive patient journey, guided by additional management tips provided by Dr. Shaji Kumar every step of the way.
Other insights
